8,320 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Spahn Wealth & Retirement LLC

Spahn Wealth & Retirement LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 8,320 shares of the medical equipment provider’s stock, valued at approximately $4,343,000. Intuitive Surgical makes up about 2.8% of Spahn Wealth & Retirement LLC’s holdings, making the stock its 15th largest holding.

Several other hedge funds have also recently added to or reduced their stakes in the business. Atala Financial Inc bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Summit Securities Group LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth about $30,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth about $31,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $507.05 on Thursday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company’s fifty day moving average price is $550.11 and its two-hundred day moving average price is $532.84. The company has a market capitalization of $180.60 billion, a price-to-earnings ratio of 79.10, a PEG ratio of 5.85 and a beta of 1.43.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Piper Sandler reissued an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Truist Financial cut their target price on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research note on Monday, March 17th. Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Royal Bank of Canada increased their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.